Eye-catching Success Story from Asia

PharmaEngine is the first company from Taiwan receiving the US FDA approval for a locally-developed new oncology drug, ONIVYDE®.

Recent Events & Presentations

See All Presentations

Recent News

Recent Financial Reports

See All Reports
Taiwan Stock Exchange
MOPS

Dividend Calendar

2017
2.000
Cash Dividend
0.000
Stock Dividend
2016
2.499
Cash Dividend
1.999
Stock Dividend